Return to homepagePandemic Pact

Clinical Efficacy Study Phase III, randomized, double blind, placebo controlled oral Polio Vaccine 1,2,3 (POV) attenuated in the Prevention or Reduction of Severity of COVID-19 in Men and Women 18 to 60 years old

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $19,600

  • Funder

    FAPESC Brazil

  • Principal Investigator

    Edison Natal Fedrizzi

  • Research Location

    Brazil

  • Lead Research Institution

    UFSC

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 3 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase III

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract